About this trial
Dehydration among older adults a costs billions of dollars in US healthcare every year because no robust solution exists to detect changes in hydration and prevent negative outcomes. In this project, TritonX Technologies Inc. and academic research partners plan to test whether a newly created wearable sensor that measures hydration in real time can promote hydration and prevent the dehydration illnesses.
The investigators will conduct a randomized controlled trial to examine the effectiveness of continuous home monitoring of fluid levels in a cohort of vulnerable older adult patients seen in the emergency care setting.
The goal of this randomized control trial is to examine the effectiveness of continuous home monitoring of fluid levels in older patients presenting to the emergency department for dehydration. The main questions it aims to answer:
1. Can a wearable device accurately determine the severity of dehydration at home and 2. can a wearable device and continuous feedback from the device change behavior in the outpatient setting that can lead to improved outcomes in the treatment of dehydration in the elderly?
Investigators will compare device readings, hydration diaries, vital signs, blood samples, return visits to the emergency department, and to see if feedback from the device decreases signs and symptoms of dehydration and changes home management of dehydration.
Participants will be asked to:
* wear the device and monitor hydration status * record the amount of home hydration * return in 7-10 days for reassessment of dehydration
The successful outcome of this study will include evidence for the effectiveness of the home, wearable hydration monitoring device, data necessary for the FDA 510(k) and related regulatory processes and substantial enhancements to both our knowledge of older adult needs and device functionality.
Eligibility criteria
Qualifiers
adult patients aged 55 and over
rresenting to the emergency department
clinical suspicion of dehydration
treatment of dehydration/syncope with fluid resuscitation
Disqualifiers
Refusal or inability to give informed consent,
severe clinical symptom requiring escalation of care beyond fluid resuscitation (ex. vasopressors, invasive blood pressure monitoring)
presumed/confirmed diagnosis of syncope secondary to a non-dehydration cause (ex. arrhythmia, stroke, pulmonary embolism, sepsis, valvular heart disease)
inability to lay flat for the test
Trial design
Treatments tested in this trial
- Device with Phone App
- Device without Phone App
Treatment groups
Locations
Sponsors and collaborators
MetroHealth Medical Center
Lead sponsor
National Institute on Aging (NIA)
Collaborator